Biopharmaceutical industry is a highly competitive landscape. Competition is intense and all the companies develop and compete for market share for each indication, condition, and therapeutic area. Since majority of the pharmaceuticals are developed for specific indications with limited patent expiry shelf life, companies are continuously investing into research and development (R&D) to discover new biologics/drugs or entering into partnerships/collaborations, acquisitions, and mergers.
Competitive Intelligence (CI) helps drug developers/companies
to understand its competitive environment, challenges, and opportunities. CI is
a process of defining, gathering, and analyzing information regarding
competition, customers and events in the industry and distributing the valuable
insights internally to help make informed business decisions. CI allows drug
developers to continuously learn from theirs as well as others’ failures and
successes.
Key uses of CI
·
Portfolio
Analysis
·
KOLs
tracking
·
New
Opportunities
·
Competitor
Strengths/Weaknesses
No comments:
Post a Comment